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Abstract
Background: Dupuytren’s disease is a fibro-proliferative disorder affecting ~3-5% of the UK population. Current
surgical treatments for Dupuytren’s contracture (DC) include fasciectomy and fasciotomy. We assessed the clinical
management of DC in England over a 5-year period; associated NHS costs were assessed for a 1-year period.
Methods: Hospital Episode Statistics were extracted from April 2003 to March 2008 for patients with Palmar Fascial
Fibromatosis (ICD10 = M720) and DC-related procedures. Variables included demographics, OPCS, patient status
and physician specialty. To estimate 2010-2011 costs, HRG4 codes and the National Schedule of Tariff 2010-11-NHS
Trusts were applied to the 2007-2008 period.
Results: Over 5 years, 75,157 DC admissions were recorded; 64,506 were analyzed. Mean admissions per year were
12,901 and stable. Day cases increased from 42% (2003-2004) to 62% (2007-2008). The percent of patients having two
or more admissions per year increased from 5.5% in 2003-2004 to 26.1% in 2007-2008. Between 2003 and 2007, 91%
of procedures were Fasciectomy. Revision of Fasciectomy and Fasciotomy each accounted for ~4%; Amputation for
1%. In 2007, classification was extended to identify Digital Fasciectomy, its Revision and Dermofasciectomy. In 2007-
2008, admissions were: 70% Palmar Fasciectomy, 16% Digital Fasciectomy, 1.3% Other Fasciectomy, 4.4% Revision of
Palmar Fasciectomy, 1.3% Revision of Digital Fasciectomy, 3.8% Division of Palmar Fascia, 2.6% Dermofasciectomy
and 1.1% Amputation. 79% of cases were overseen by trauma and orthopaedic surgeons, 19% by plastic surgeons.
Mean (±SD) inpatient hospital length of stay was 1.5 (±1.4) days in 2003-2004 and 1.0 (±1.3) days in 2007-2008. Total
estimated costs for 1 year (2010-2011) were £41,576,141. Per-patient costs were £2,885 (day case) and £3,534
(inpatient). Costs ranged from £2,736 (day-case Fasciectomy) to £9,210 (day-case Revision Digital).
Conclusions: Between 2003 and 2008, fasciectomy was the most common surgical procedure for DC in England.
While procedure rates and physician specialties varied little, there was a reversal in surgical venue: inpatient
operations decreased as day-case procedures increased. The change is likely due to economic trends and changes
to the healthcare system. Estimated costs for 2010-2011 varied by procedure type and patient status. These
findings can be used to understand clinical management of DC and guide healthcare policy.
Background
Dupuytren’s disease is a fibro-proliferative disorder
affecting the palmar fascia whereby early nodular tissue
becomes acellular, and a thick collagen cord develops.
As the cord contracts, flexion deformity of the affected
metacarpophalangeal or proximal interphalangeal joint
ensues. Joint contracture is a common presenting com-
plaint, as it can impair hand function at home, in the
workplace and in social interactions [1]. There is no
cure for Dupuytren’s disease; however, treatment goals
include removing or releasing the fibrotic cord to allow
extension of the affected finger(s) and restoration of
hand function. Common surgical approaches include
limited fasciectomy (aponeurectomy), fasciotomy (apo-
neurotomy), percutaneous needle aponeurotomy and
dermofasciectomy. The type of approach used depends
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age, comorbid conditions and severity of disease.
W h i l ei ti sg e n e r a l l ya s s u m e dt h a tt h em a j o r i t yo f
patients with Dupuytren’s disease are native to or des-
cendents of ancestors from northern Europe, epidemio-
logic studies have been conducted in numerous
countries. Although published prevalence estimates vary
widely, most studies have shown that prevalence
increases with advancing age [2,3].
To our knowledge, the only published study to assess
hospital costs associated with Dupuytren’sd i s e a s ew a s
conducted by Maravic and Landais in France in 2005. In
this study, we evaluated the clinical management of
Dupuytren’s disease over a 5-year period in England
using data extracted from a National Health Service
(NHS) database. Variables of interest included patient
demographics, the types and frequencies of surgical pro-
cedures, day-case or inpatient admission status, and the
specialty of the treating physician. Associated costs were
estimated for a 1-year period. The aim of the study was
to describe surgical treatment patterns and the asso-
ciated costs for Dupuytren’s contracture in England.
Methods
Hospital Episode Statistics (HES) were extracted for 5
complete years between 2003 and 2008 (April-March
periods) for subjects with a diagnosis code for Palmar
Fascial Fibromatosis (International Classification of Dis-
eases [ICD]-10 = M720). The database, provided by
Caspe Healthcare Knowledge Systems (CHKS), contains
details about admissions to NHS hospitals in England,
including acute hospitals, primary care trusts and mental
health trusts. It includes private patients treated in NHS
hospitals, and patients who reside outside of England but
receive care from treatment centres funded by the NHS.
The database excludes patients treated in the private sec-
tor where the treatment is not funded by the NHS.
HES-based patient records contain demographic (eg,
age, gender, ethnicity, residence, treatment location),
clinical (eg, diagnoses, procedure codes), and adminis-
trative information (eg, dates of admission/discharge,
time waited). For this analysis, information on subject
demographics, Office of Population Census and Survey
(OPCS)-4 codes (surgical procedure codes), day-case
and hospital admissions, and treating physician specialty
were collected. For each year, resource utilization was
determined for all patients with an admission for
Dupuytren’s contracture, and the number of hospitaliza-
tions, length of hospital stay for Dupuytren’sc o n t r a c -
ture, and type of admission (day case versus inpatient)
were recorded. For this analysis, a hospital admission
was defined as any case where a patient is admitted to a
hospital as either a day case (a visit that excludes an
overnight stay) or inpatient (≥1n i g h ts t a yi nt h e
hospital). Elective procedures were defined as planned/
scheduled; non-elective procedures were defined as
unplanned/emergency.
Payment by results, introduced across the NHS in
England and Wales in 2005, uses healthcare resource
groups (HRGs) as a measure of care, based on both the
diagnosis and the complexity of treatment. Their pur-
pose is to group together similar clinical treatments that
should cost an equivalent amount to deliver. This sys-
tem aims primarily to provide a structure of a national
fixed tariff, with a secondary aim to improve productiv-
ity and increase capacity throughout the NHS [4]. An
individual tariff, which is based on a reference cost (ie,
the weighted average costs for all English hospitals, is
related to actual costs of a procedure. At least one code
is assigned to each hospital episode to be funded by the
patient’s primary care trust [5]. The HRG4 codes are
derived from a combination of diagnostic (ICD-10) and
procedure (OPCS-4) codes derived from the patient’s
records [6]. To estimate total and per-patient costs, the
2010-2011 NHS National Schedule of Tariff [7] was
mapped to the 2007-2008 procedure HRG4 treatment
groupings to value all admissions. Per-patient costs were
calculated because they provide the best estimate of a
complicated case mix of multiple HRG codes and differ-
ent frequencies of day-case and inpatient admissions.
Costs associated with ancillary services such as follow-
up visits and physiotherapy were not included.
All results are reported descriptively. Categorical data
are presented as counts (n) and proportions (%). Contin-
uous data are presented as mean (standard deviation
[SD] and/or as median (inter-quartile range [IQR]). All
data were analyzed using Microsoft Excel and conducted
under Windows XP Professional.
Results
A total of 75,157 admissions (day case or inpatient) for
Palmar Fascial Fibromatosis (ICD10 = M720) as either a
primary or subsidiary diagnosis were recorded in Eng-
land between April 2003 and March 2008. Of these,
71,103 admissions (94.6%) were considered for further
analysis (4,054 admissions were excluded due to unre-
lated patient death, no recorded procedure or trauma).
The records were more closely reviewed, and an addi-
tional 6,597 patients were excluded because there was
no reference to a procedure to correct Dupuytren’sc o n -
tracture having been conducted at that admission.
The current analyses are based upon 64,506 evaluable
hospital admissions recorded during the 5-year period
(Figure 1). Of this total, 51,284 (80%) were male patients
(63 ± 11 y), and 13,220 (20%) were female patients (66 ±
11 y). These figures varied little over time. The number
of admissions per year was 12,901 ± 330 and also
remained stable.
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Page 2 of 10Overall, day-case admission rates increased from 42%
in 2003-2004 to 62% in 2007-2008, and inpatient admis-
sion rates decreased from 58% to 38%, respectively (Fig-
ure 2). Between April 2003 and March 2007,
Fasciectomy (Palmar [T521], Other specified excision
[T528] and Unspecified excision [T529]) accounted for
91% of elective procedures performed. Revision of Pal-
mar Fasciectomy (T522) and Division of Palmar Fascia
(T541) each accounted for ~4% of procedures; Amputa-
tions (X083, X084, X088) accounted for the remaining
1%. Between April 2007 and March 2008, Fasciectomy
rates decreased to 71%, owing to the introduction of
codes for Digital Fasciectomy (T525), its Revision
(T526) and Dermofasciectomy (T561), which together
accounted for 20% of procedures that year. Rates for the
other procedures remained unchanged. There were no
differences in procedure rates by year between day-case
(Table 1) and inpatient admissions (Table 2).
Overall, 79% of admissions were overseen by trauma
and orthopaedic surgeons and 19% by plastic surgeons;
these proportions varied by less than ±1% in each 12-
month period. Few admissions were overseen by physi-
cians outside these specialties: about 1% (n = 612) were
performed by emergency physicians and <0.5% (n = 181)
by general surgeons over the 5-year period (Table 3).
Although the most commonly performed procedure
across surgical specialties was fasciectomy, orthopaedic
and plastic surgeons performed a wider variety of
procedures.
Between April 2003 and March 2004, 7,259 admis-
sions received a Dupuytren’s contracture procedure that
was recorded as having been performed on an inpatient
basis, which was defined a priori as ≥1-night stay in hos-
pital. However, for 13% (n = 910) of these admissions,
patients were discharged on the same day of the proce-
dure. In fact, these percentages rose steadily thereafter,
up to 26% in 2008. Within each 12-month period, the
largest percentage of miscoded inpatient admissions was
for Amputations, although the overall frequency of these
procedures was relatively low. For the majority of proce-
dures performed in 2007-2008, more than 25% were
miscoded as inpatient admissions. Length of stay
decreased slightly from 1.48 ± 1.4 days in 2003-2004 to
1.03 ± 1.2 days in 2007-2008; however, variation from
year to year and across procedures was quite large
(Table 4). Lastly, the number of admissions per patient
per year for a Dupuytren’s procedure increased steadily
between 2003 and 2008. In 2008, 26% of patients had
two or more admissions for a Dupuytren’s procedure
(Figure 3).
Per-patient and total estimated costs for 2010-2011
varied by procedure type and patient status (Table 5).
One-year total costs for DC were £41,576,141. Day case
and inpatient admissions accounted for 57%
CHKS database:
Admissions with M720 diagnosis = 75,157
Source population of admissions = 71,103
Study cohort = 64,506
Exclusions 4,054  (5.4%)
   Deaths 67  (<1%)
   No OPCS code  2,963 (3.9%)
   Significant trauma  1,014 (1.4%)
Exclusions       6,597 (9.3%)
   No Dupuytren’s contracture
   procedure  247 (0.4%)
   Different condition  6,350 (8.9%)
Figure 1 Patient flow.
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Page 3 of 10(£23,834,242) and 43% (£17,741,900) of total costs,
respectively. Overall, mean per-patient costs were £2,885
(day case) and £3,534 (inpatient). Per-patient costs for
Palmar Fasciectomy were £2,736 for day cases and
£2,785 for inpatients; respective costs for Digital Fas-
ciectomy were £3,148 and £5,142. Per-patient costs for
Palmar Revision were £2,794 for day cases and £4,332
for inpatients; respective costs for Digital Revision were
£9,210 and £9,208. The majority of costs (82%;
£33,938,028) were for fasciectomy procedures. Revisions
of a fasciectomy accounted for 9% (£3,617,572) of total
costs (Table 6).
Discussion
We extracted and reviewed HES data to evaluate trends
in the clinical management of Dupuytren’s disease in
England during the 5-year period from April 2003
through March 2008 and to estimate 1-year NHS costs
for 2010-2011. Specifically, we systematically summar-
ized information about the total number of hospital
admissions and the average length of stay, the types of
surgical procedures used and the frequency with which
they were performed and by whom, and whether these
procedures were performed on a day-case or inpatient
basis.
Overall, the mean number of admissions remained
fairly stable from year to year, and patient demographics
such as mean age and gender distribution varied little
over time. Similarly, in a 10-year review of data from
the Pulvertaft Hand Centre, there was little change in
the age of presenting patients between 1990 and 2000
[8]. Between 2003 and 2007, the vast majority (91%) of
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Figure 2 Day-case and inpatient admission rates by year and type of Dupuytren’s procedure.
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Page 4 of 10elective procedures were coded as Fasciectomy (Palmar,
Other, Unspecified); the remaining procedures were
coded as Revision of Fasciectomy (4%), Fasciotomy (4%)
and Amputation (1%). Procedure rates were also stable
during this time, and rates for day cases versus
inpatients were comparable. Between 2007 and 2008,
traditional Fasciectomy rates declined to 71%, owing to
the introduction of OPCS codes for Digital Fasciectomy,
its Revision and Dermofasciectomy, which accounted for
16%, 1.3% and 2.6% of procedures, respectively, during
Table 1 Summary of Dupuytren’s contracture procedures for day-case admissions by OPCS code and year
OPCS Description 2003-2004 2004-2005 2005-2006 2006-2007 2007-2008
Code Fasciectomy n%n%n%n%n%
T521 Palmar Fasciectomy 4,722 88.8 5,021 88.2 5,701 88.9 6,736 87.2 5,888 71.2
T525 Digital Fasciectomy –––––––– 1307 15.8
T528 Other specified excision of other fascia 39 0.7 50 0.9 79 1.2 146 1.9 30 0.4
T529 Unspecified excision of other fascia 63 1.2 89 1.6 90 1.4 130 1.7 54 0.7
Total 4824 90.7 5160 90.7 5870 91.5 7012 90.7 7279 88.0
Revision of Fasciectomy
T522 Revision of Palmar Fasciectomy 176 3.3 189 3.3 213 3.3 320 4.1 322 3.9
T526 Revision of Digital Fasciectomy –––––––– 90 1.1
Total 176 3.3 189 3.3 213 3.3 320 4.1 412 5.0
Fasciotomy
T541 Division of Palmar Fascia 264 5.0 298 5.2 272 4.2 330 4.3 352 4.3
Dermofasciectomy
T561 Dermofasciectomy –––––––– 134 1.6
Amputations
X083 Amputation of phalanx of finger 10 0.2 7 0.1 18 0.3 20 0.3 28 0.3
X084 Amputation of finger NEC 43 0.8 35 0.6 38 0.6 45 0.6 64 0.8
X088 Other specified amputation of hand 2 0.0 1 0.0 1 0.0 1 0 0 0.0
Total 55 1.0 43 0.8 57 0.9 66 0.9 92 1.1
Grand Total 5,319 5,690 6,412 7,728 8,269
Table 2 Summary of Dupuytren’s contracture procedures for inpatient admissions by OPCS code and year
OPCS 2003-2004 2004-2005 2005-2006 2006-2007 2007-2008
Code Fasciectomy n%n%n%n%n%
T521 Palmar Fasciectomy 6,355 87.5 5,975 86.7 5,661 87.6 4,706 86.4 3,352 66.7
T525 Digital Fasciectomy –––––––– 819 16.3
T528 Other specified excision of other fascia 168 2.3 182 2.6 97 1.5 113 2.1 43 0.9
T529 Unspecified excision of other fascia 56 0.8 78 1.1 52 0.8 47 0.9 42 0.8
Total 6,579 90.6 6235 90.4 5,810 89.9 4,866 89.3 4,256 84.7
Revision of Fasciectomy
T522 Revision of Palmar Fasciectomy 309 4.3 347 5.0 370 5.7 344 6.3 266 5.3
T526 Revision of Digital Fasciectomy –––––––– 80 1.6
Total 309 4.3 347 5.0 370 5.7 344 6.3 346 6.9
Fasciotomy
T541 Division of Palmar Fascia 279 3.8 232 3.4 198 3.1 180 3.3 154 3.1
Dermofasciectomy
T561 Dermofasciectomy –––––––– 210 4.2
Amputations
X083 Amputation of phalanx of finger 24 0.3 21 0.3 20 0.3 11 0.2 11 0.2
X084 Amputation of finger NEC 66 0.9 59 0.9 61 0.9 45 0.8 48 1.0
X088 Other specified amputation of hand 2 0.0 1 0.0 3 0.0 0.0 1 0.0
Total 92 1.3 81 1.2 84 1.3 56 1.0 60 1.2
Grand Total 7,259 6,895 6,462 5,446 5,026
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Page 5 of 10this 12-month period. One-year total costs for DC were
£41,576,141 with day cases accounting for 57%
(£23,834,242) of total costs. Mean per-patient costs were
£2,885 (day case) and £3,534 (inpatient). Because costs
associated with follow-up visits and physiotherapy were
not included in the analysis, the values are highly likely
to be underestimates of the total direct costs of the
management of Dupuytren’s disease in England.
Few studies have assessed the treatment costs on a
national level for Dupuytren’sd i s e a s e .T oo u rk n o w l -
edge, our cost analysis was the first conducted for Eng-
land for Dupuytren’s disease. Using the French National
Database, Maravic and Landais conducted a similar
study to evaluate elective admissions of men and
women (aged ≥46 y) with a primary ICD-10 diagnosis
code (ie, M72.0, M72.00, M72.04, M27.09) and surgical
code for Dupuytren’s disease in 2001. In total, 14,860
cases were identified. Four procedures were described:
needle fasciotomy, surgical fasciectomy of one finger,
surgical fasciectomy of two or more fingers, and re-
intervention [9]. Overall, a Dupuytren’s procedure
occurred mostly in men (82%), was managed primarily
in private hospitals (77%) with a short length of stay
(≤24 h; 53%), and fasciectomy was the most common
surgical procedure (88%). Total hospital costs (2005) for
all elective admission was €14,179,998 [9]. In a retro-
spective analysis of hospital admissions spanning 50
years, Loos et al [10] showed that between 1988 and
2006, 95% (1,061/1,119) of operated Dupuytren’s disease
patients had a limited fasciectomy, 5% (58/1,119) had
total fasciectomy, and 1% (13/1,119) had amputations.
Of this total, 12% of surgeries were for recurrent con-
tracture [10].
For each year of the 5-year period, we show that the
majority of Dupuytren’s contracture procedures were
performed by trauma and orthopaedic surgeons (79%)
followed by plastic surgeons (19%); a small percentage
of procedures were performed by emergency physicians
or general surgeons. In a similar analysis of HES data
for 2001, Hobby and Dias showed that three main
Table 3 Procedures for Dupuytren’s contracture by physician specialty and OPCS code
OPCS Trauma & Orthopaedic Plastic Surgery Accident & Emergency General Surgery
Code Description n % n % n % n %
T521 Palmar Fasciectomy 42,959 66.6 10,401 16.1 536 0.8 166 0.3
T525 Digital Fasciectomy 1,579 2.4 531 0.8 14 0.0 1 0.0
T528 Other specified excision of other fascia 741 1.1 202 0.3 0 0.0 4 0.0
T529 Unspecified excision of other fascia 565 0.9 130 0.2 4 0.0 0 0.0
T522 Revision of Palmar Fasciectomy 2,250 3.5 568 0.9 37 0.1 0 0.0
T526 Revision of Digital Fasciectomy 148 0.2 22 0.0 0 0.0 0 0.0
T541 Division of Palmar Fascia 2,188 3.4 334 0.5 16 0.0 9 0.0
T561 Dermofasciectomy 223 0.3 121 0.2 0 0.0 0 0.0
X083 Amputation of phalanx of finger 124 0.2 46 0.1 0 0.0 0 0.0
X084 Amputation of finger NEC 412 0.6 86 0.1 5 0.0 1 0.0
X088 Other specified amputation of hand 9 0.0 3 0.0 0 0.0 0 0.0
Total 51,198 79.4 12,444 19.3 612 0.9 181 0.3
Table 4 Length of stay for inpatient admissions by year and OPCS code
OPCS 2003-2004 2004-2005 2005-2006 2006-2007 2007-2008
Code Description Mean SD Mean SD Mean SD Mean SD Mean SD
T521 Palmar Fasciectomy 1.48 1.34 1.35 2.56 1.29 1.42 1.17 1.61 1.04 1.31
T525 Digital Fasciectomy –––––––– 0.97 1.04
T528 Other specified excision of other fascia 1.60 1.08 1.48 0.81 1.16 1.04 1.05 0.95 0.98 0.94
T529 Unspecified excision of other fascia 1.30 1.01 1.37 0.97 1.08 0.84 0.87 0.68 1.31 2.09
T522 Revision of Palmar Fasciectomy 1.54 1.95 1.31 1.09 1.28 1.07 1.23 0.96 1.10 1.02
T526 Revision of Digital Fasciectomy –––––––– 0.89 0.75
T541 Division of Palmar Fascia 1.57 2.47 1.14 1.17 1.16 1.25 1.44 3.48 0.95 0.92
T561 Dermofasciectomy –––––––– 1.14 0.76
X083 Amputation of phalanx of finger 1.38 1.10 1.05 0.80 1.10 1.09 1.18 0.98 0.91 0.70
X084 Amputation of finger NEC 1.32 1.45 1.41 1.10 1.07 1.30 1.07 0.78 1.02 0.96
X088 Other specified amputation of hand 2.50 0.71 1.00 0 1.00 0 0 0 0 0
Overall 1.48 1.42 1.35 2.41 1.28 1.39 1.17 1.65 1.03 1.22
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Page 6 of 10surgical specialties treated hand conditions: 67% were
orthopaedic surgeons and 31% were plastic surgeons. A
small percentage (1%) was represented by trauma sur-
geons [11]. In a 6-month study of 76 consecutive Danish
patients with advanced Dupuytren’s disease, day case
surgery was performed on 96% (50/52) of patients with
primary contracture and 79% (19/24) of those with
recurrent disease [12]. Senior registrars from the
Department of Orthopaedic Surgery performed 89% of
primary surgeries and 50% of recurrent surgeries. The
remaining 50% of recurrent surgeries were performed by
a specialist in hand surgery. There were no differences
between the primary and recurrent group in terms of
complications; however, 10% of primary cases had perio-
perative nerve injuries [12]. Both studies concluded that
all surgeries for Dupuytren’s disease should be per-
formed by experienced surgeons with proper training in
hand surgery.
While our findings show minimal changes in the
number of admissions per year, patient demographics,
procedure rates, and physician specialty between April
2003 and March 2008, there was a clear reversal in the
distribution of admissions treated as day cases versus
inpatients. In 2000, the Department of Health’sN H S
Plan recommended that 75% of elective admissions
should be day cases [13], and excision of Dupuytren’s
contracture is among the 25 ‘basket’ procedures that
should normally be performed as such [14]. In one
report, the percentage of day-case versus inpatient pro-
cedures for Dupuytren’s contracture was 30% in 1996-
1997; by 2003-2004, the rate had increased to 43% [15].
In our study, day-case admission rates increased from
42% in 2003-2004 to 62% in 2007-2008. These results
are also comparable to those reported by The Health
Commission in their latest review of HES data: day-case
rates for Dupuytren’s contracture excision rose gradually
from ~35% in 1998-1999 to ~40% in 2003-2004 [14]. In
the Healthcare Commission report, day-case procedure
rates for Dupuytren’s contracture were classified as ‘still
rising’ at a medium-to-high rate [14], which is consistent
with our findings for 2007-2008. Interestingly, between
April 2007 and March 2008, while the number of
admissions recorded as inpatients fell by 31%, the pro-
portion that did not have an overnight stay doubled to
26% (n = 1295). Indeed, there was a steady increase in
the number of admissions coded as inpatient (requiring
≥1-night stay in hospital), but where the patient was dis-
charged the same day. When a patient did have a hospi-
tal stay, the mean duration was 1.5 days in 2003-2004
and 1 day in 2007-2008.
The review of HES data suggests that the number of
admissions per patient per year for a Dupuytren’s proce-
dure increased steadily between 2003 and 2008. One
possible explanation is an increase in the staging of cor-
rective procedures by surgeons who are more concerned
about achieving positive outcomes. By contrast, it may
be that surgeons are rushing procedures owing to
diminished resources that may include a shortage of
qualified surgeons and/or decreased operating theatre
time. This may result in an increased incidence of
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Page 7 of 10infection, graft failure or other complications that
require additional admission. A third option is that as
waiting lists decrease, patients with multiple affected
joints in the same hand or bilateral contractures can
receive more than one procedure in a single calendar
year.
Historically and relative to other Western countries,
the UK has been slow to adopt a day-case approach to
surgery for Dupuytren’s disease [16]. In the early 1990s,
a survey of 24 hand surgeons showed that 25% never
carried out Dupuytren’s surgery on a day-case basis; the
remaining surgeons did so occasionally. In no case was
day-case surgery part of their routine practice; 71%
admitted patients for ≥2 nights [16]. In a follow-up
study to investigate the effectiveness of regional anaes-
thesia and the safety of surgery performed on a day-case
basis, the investigators used brachial plexus block and
local fasciectomy in 50 Dupuytren’s disease patients. No
patient required general anaesthesia and only one
patient who experienced a hypotensive episode during
surgery was admitted overnight. All other patients were
discharged later the same day [16]. Similarly, during a 6-
month study conducted at the Pulvertaft Hand Centre,
1,003 patients presented for elective hand surgery.
Table 5 Summary of 1-year (2010-2011) total and per-patient costs by OPCS code, HRG code and admission type
Procedures HRG Mean Total Costs (£) Mean Per-Patient Costs (£)
OPCS Description n (%) Code Day Case Inpatient All Day Case Inpatient All
T521 Palmar Fasciectomy 9,240 (69.5) HB53Z 15,778,965 8,856,210 24,365,176
HB52C 213,008 257,761 470,769
HB52B 94,066 206,328 3,000,394
Total 16,086,039 9,320,300 25,406,338 2,736 2,785 2,750
T525 Digital Fasciectomy 2,126 (16.0) HB51Z 3,976,776 4,128,570 8,105,346
HA06Z 138,075 82,845 220,920
Total 4,114,851 4,211,415 8,326,266 3,148 5,142 3,916
T528 Other specified excision of other fascia 73 (0.5) HB55C 26,180 30,940 5,7120
HB55B 8,806 18,870 27,676
HB54C 1,880 3,760 5,640
Total 36,866 53,570 90,436 1,229 1,246 1,239
T529 Unspecified excision of other fascia 96 (0.7) HB55C 57,120 44,030 101,150
HB55B 7,548 6,290 13,838
Total 64,668 50,320 114,988 1,198 1,198 1,198
T522 Revision of Palmar Fasciectomy 588 (4.4) HB52C 645,460 581,803 1,227,263
HB52B 229,632 432,960 662,592
HB51Z 24,624 137,619 162,243
Total 899,716 1,152,382 2,052,098 2,794 4,332 3,490
T526 Revision of Digital Fasciectomy 170 (1.3) HA06Z 810,040 727,195 1,537,235
HA05Z 18,826 9,413 28,239
Total 828,866 736,608 1,565,474 9,210 9,208 9,209
T541 Division of Palmar Fascia 506 (3.8) HB55C 320,110 94,010 414,120
HB55B 88,060 81,770 169,830
HB54C 15,040 3,760 18,800
HB54B 10,860 17,376 28,236
Total 434,070 196,916 630,986 1,233 1,279 1,247
HA06Z 1,205,855 1,914,640 3,120,495
T561 Dermofasciectomy 344 (2.6) HA05Z 28,239 18,826 47,065
Total 1,234,094 1,933,466 3,167,560 9,210 9,207 9,208
X083 Amputation of phalanx of finger HB55C 55,930 29,750 85,680
HB54C 43,240 13,160 56,400
X084 Amputation of finger NEC 152 (1.1) HB55B 16,354 23,902 40,256
HB54B 19,548 17,376 36,924
X088 Other specified amputation of hand HB53Z 0 2,735 2,735
Total 135,072 86,923 221,995 1,468 1,449 1,460
Overall total costs in England 23,834,242 17,741,900 41,576,141 2,885 3,534 3,127
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Page 8 of 10Between 1990 and 2000, the referral rate for elective
surgeries had increased by 36%, from 289 to 392 per
100,000 population per year. The day-case surgery rate
increased from 64% to 94%, and the number of inpatient
days decreased from 221 to 210 per 100,000 population
per year [17]. Dupuytren’s disease was the fifth most
common elective surgery performed in the clinic at 33
per 100,000 population per year. Thus, Dupuytren’sd i s -
ease accounted for 8% of the elective hand surgeries
during the time period examined.
These findings should be considered in light of some
limitations. First, although care is taken to avoid inac-
curacies in the HES database - and CHKS audits more
than 60% of records - there will be errors and omissions
that are not reviewed and/or corrected on an ongoing
basis. It is reasonable to assume, however, that such
inaccuracies are random occurrences and no systematic
biases are introduced. As a census-based study, there
a r en oe t h n i co rg e o g r a p h i cb i a s e si nt h ed a t a ;t h e ya r e
representative of the overall population in England that
receives hospital-based care for Dupuytren’s contracture.
Nevertheless, the database does not include information
about procedures conducted as an outpatient or from
patients treated in the private sector, so results cannot
be generalized to these subpopulations in England.
Conclusions
Between 2003 and 2008, fasciectomy was the most com-
mon and most costly surgical procedure for Dupuytren’s
contracture in England. While procedure rates and phy-
sician specialties varied little during this time, there was
a marked change in patient status and overnight stays:
inpatient operations decreased as day-case procedures
increased. The change was likely due to economic
trends and modifications to the healthcare system in
England. Future studies are warranted to monitor these
trends and the associated effects on outcomes and costs.
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Table 6 Summary of 1-year (2010-2011) total costs by OPCS code, admission type and percentage of total costs
Day Case Inpatient All Admissions
OPCS Description Costs (£) % Costs (£) % Costs (£) %
T521 Palmar Fasciectomy 16,086,039 67.5 9,320,300 52.5 25,406,338 61.1
T525 Digital Fasciectomy 4,114,851 17.3 4,211,415 23.7 8,326,266 20.0
T528 Other specified excision of other fascia 36,866 0.2 53,570 0.3 90,436 0.2
T529 Unspecified excision of other fascia 64,668 0.3 50,320 0.3 114,988 0.3
Fasciectomy total 20,302,424 85.2 13,635,605 76.9 33,938,028 81.6
T522 Revision of Palmar Fasciectomy 899,716 3.8 1,152,382 6.5 2,052,098 4.9
T526 Revision of Digital Fasciectomy 828,866 3.5 736,608 4.2 1,565,474 3.8
Revision total 1,728,582 7.3 1,888,990 10.6 3,617,572 8.7
T541 Fasciotomy 434,070 1.8 196,916 1.1 630,986 1.5
T561 Dermofasciectomy 1,234,094 5.2 1,933,466 10.9 3,167,560 7.6
X083,
X084,
X088
Amputation 135,072 0.6 86,923 0.5 221,995 0.5
Gerber et al. BMC Musculoskeletal Disorders 2011, 12:73
http://www.biomedcentral.com/1471-2474/12/73
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